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Abstract
Background: Cajal bodies (CBs) are nuclear suborganelles that play a role in the biogenesis of
small nuclear ribonucleoproteins (snRNPs), which are crucial for pre-mRNA splicing. Upon nuclear
reentry, Sm-class snRNPs localize first to the CB, where the snRNA moiety of the snRNP is
modified. It is not clear how snRNPs target to the CB and are released from this structure after
their modification. Coilin, the CB marker protein, may participate in snRNP biogenesis given that
it can interact with snRNPs and SMN. SMN is crucial for snRNP assembly and is the protein
mutated in the neurodegenerative disease Spinal Muscular Atrophy. Coilin knockout mice display
significant viability problems and altered CB formation. Thus characterization of the CB and its
associated proteins will give insight into snRNP biogenesis and clarify the dynamic organization of
the nucleus.
Results: In this report, we identify a novel protein isoform of EB-1/AIDA-1, termed AIDA-1c, that
interacts with the CB marker protein, coilin. Northern and nested PCR experiments reveal that
the AIDA-1c isoform is expressed in brain and several cancer cell lines. Competition binding
experiments demonstrate that AIDA-1c competes with SmB' for coilin binding sites, but does not
bind SMN. When ectopically expressed, AIDA-1c is predominantly nuclear with no obvious
accumulations in CBs. Interestingly, another EB-1/AIDA-1 nuclear isoform, AIDA-1a, does not bind
coilin in vivo as efficiently as AIDA-1c. Knockdown of EB-1/AIDA-1 isoforms by siRNA altered
Cajal body organization and reduced cell viability.
Conclusion:  These data suggest that specific EB-1/AIDA-1 isoforms, such as AIDA-1c, may
participate in the regulation of nucleoplasmic coilin protein interactions in neuronal and
transformed cells.
Background
Studies conducted to understand nuclear organization
and function have revealed that the nucleus contains a
myriad of dynamic, highly organized domains, territories
and bodies [1-3]. The Cajal body (CB) is one such struc-
ture and contains the highest concentration of small
nuclear ribonucleoproteins (snRNPs) in the nucleus [4,5].
SnRNPs are a vital part of the pre-mRNA processing
machinery, necessary for both splice site recognition and
the splicing reaction. More precisely, the catalyst for the
splicing reaction is probably the small nuclear ribonucleic
acid (snRNA) component of the snRNP [6]. The human
U1, U2, U4, U5 and U6 snRNAs share the intriguing char-
acteristic in that they contain numerous post-transcrip-
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tionally modified nucleotides, namely pseudouridines
and 2'-O-methyl groups [7]. These modifications appear
to be important for efficient splicing of RNA and, in the
case of U2, are essential for spliceosomal assembly [8]. In
addition to base modification, U1, U2, U4 and U5
snRNAs undergo an elaborate maturation pathway in
which they are exported to the cytoplasm. In the cyto-
plasm, these snRNAs are substrates for the survival of
motor neurons (SMN) protein [9]. Mutations in SMN
cause the neurodegenerative disorder Spinal Muscular
Atrophy [10]. SMN is essential for the assembly of core Sm
proteins (B/B', D3, D1, D2, E, F, and G) onto the snRNA
[11], and participates in additional modification steps
and the import of nascent snRNPs into the nucleus
[12,13].
After their transport into the nucleus, newly formed
snRNPs accumulate first in the CB and then localize to
interchromatin granule clusters, which are also known as
speckles [14]. Recent work from the groups of Kiss and
Bertrand has shown that CBs contain small guide RNAs,
termed small Cajal body-specific RNAs (scaRNAs), which
localize exclusively to the CB and guide modifications of
U1, U2, U4 and U5 snRNA by pseudouridylation and 2'-
O-methylation [15,16]. Additional work from this same
group demonstrates that these snRNAs are indeed subject
to base modification in the CB after import from the cyto-
plasm [17]. For example, short fragments of Sm snRNAs
are modified when they are targeted to the CB, but are not
modified when targeted to the nucleolus. Other work has
shown that telomerase RNA shares structural similarities
to scaRNAs and is also enriched within the Cajal body
[18,19]. It is possible, therefore, that CBs may play a role
in the assembly of the telomerase holoenzyme in addition
to its clear role in snRNA modification. Still additional
work implicates CBs in U4/U6 assembly [20,21], U4/
U6.U5 tri-snRNP recycling [22], U2 snRNP biogenesis
[23] and U3 small nucleolar RNA transport [24].
The marker protein for the CB is considered to be coilin,
but the majority (70%) of coilin is actually diffusely local-
ized throughout the nucleoplasm [25]. Although coilin is
conserved among vertebrates and homologues are present
in plants, a corresponding gene has not been identified in
worms and flies [4]. Nevertheless, CB-like structures are
present in a variety of insects, including Drosophila
[26,27]. The accumulation of snRNPs within CBs is con-
tingent upon coilin [28-30] and characterization of coilin
knockout mice demonstrates that inbred strains have sig-
nificant viability and fertility defects [29]. Cell lines
derived from coilin knockout mice do not have CBs, but
instead have residual CBs which fail to accumulate
snRNPs or SMN [29]. Thus while not an essential protein,
coilin likely plays an important role in coordinating the
activities of various types of RNA processing machineries
into a common nuclear structure [4,31,32].
Coilin has been shown to interact directly with SMN and
various Sm proteins and can compete with SmB' for bind-
ing sites on SMN [30]. The interaction between coilin and
SMN has been found to be contingent upon several
arginine/glycine (RG) dipeptide repeats present within
coilin [30]. These arginines are symmetrically dimethyl-
ated, increasing the affinity of SMN for coilin [33,34]. In
the nucleus, SMN localizes in most cell types and cell lines
to CBs [1]. Curiously, SMN exists in some cell lines and
fetal tissues in discrete nuclear structures termed "gems"
(for Gemini of Cajal bodies) [35,36]. The presence of
SMN gems correlates with a decrease in coilin methyla-
tion [33,34].
It is not yet understood how nascent snRNPs are targeted
to the CB for modification. Also unclear is how snRNPs
are released from the CB after modification of the snRNA
moiety takes place. Moreover, the function of coilin in the
nucleoplasm, where the majority of the protein is found,
remains elusive. In this work, we identify a novel protein
isoform of the EB-1/AIDA-1 gene, AIDA-1c, as a coilin
interacting protein. Expression analysis demonstrates that
AIDA-1c is present in neuronal tissue and cancer cell lines.
AIDA-1c competes with SmB' for coilin binding sites and
localizes predominantly to the nucleoplasm when ectopi-
cally expressed. Other EB-1/AIDA-1 isoforms, in particu-
lar AIDA-1a, have been shown to interact with the
amyloid-β  protein precursor (Aβ PP) intracellular domain
(AID) [37,38]. All known EB-1/AIDA-1 isoforms contain
a conserved phosphotyrosine binding (PTB) domain,
indicating a role in signal transduction and/or pro-
tein:protein interaction [39,38]. Interestingly, AIDA-1a
does not interact with coilin in vivo as efficiently as AIDA-
1c. These findings suggest that specific EB-1/AIDA-1 iso-
forms, such as AIDA-1c, may participate in the regulation
of nucleoplasmic coilin protein interactions, and thereby
indirectly affect CB activity in neuronal and transformed
cells.
Results and discussion
Isolation of AIDA-1c
To broaden our understanding of Cajal bodies and coilin,
we conducted a yeast two-hybrid screen with coilin as
bait. We chose a human brain cDNA library for this assay
because we are interested in assessing CB protein dynam-
ics in neuronal tissue, which is the cell type primarily
affected in Spinal Muscular Atrophy. The C-terminal 214
aa of coilin, which contains the RG box, was the bait for
the screen. This region of coilin mediates the interaction
between coilin and SMN. Additionally, C214 of coilin is
sufficient to interact with Sm proteins [30]. Consequently,
other proteins that bind C214 may regulate the interplayBMC Cell Biology 2005, 6:23 http://www.biomedcentral.com/1471-2121/6/23
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between coilin/SMN and coilin/Sm and thus play a role in
CB dynamics. The isolation of proteins that interact with
this important region of coilin is therefore a key first step
towards understanding how RNPs are targeted to, modi-
fied within and released from the CB.
Several preys were recovered from the screen, one of
which appeared to be a partial coding sequence of an EB-
1 protein isoform. Transcription of EB-1 is activated in
t(1:19) pre-B cell acute lymphocytic leukemia [39]. This
translocation produces the chimeric oncoprotein E2a-
Pbx1, leading to the aberrant expression of three tissue-
specific genes, EB-1 among them. Recent work has identi-
fied other isoforms emanating from this gene and have
found that at least one of these proteins associates with
the Amyloid-β  Protein Precursor (Aβ PP) Intracellular
Domain (AID) and hence are termed AIDA proteins [38].
Alterations in Aβ PP processing are thought to underlie the
pathology of Alzheimer's disease. All known isoforms of
the EB-1/AIDA-1 gene contain a phosphotyrosine binding
(PTB) domain, including the apparently truncated protein
we isolated from the two-hybrid screen. PTB domains
were initially characterized as protein interaction modules
that bind to regions containing phosphotyrosine [40].
However, these domains have also been found to be
important for protein:protein interaction in the absence
of phosphotyrosine, possibly serving as a platform for a
broad range of associations [41]. In addition to the PTB
domain, some isoforms of EB-1/AIDA-1 contain other
protein interaction domains such Sterile Alpha Motifs
(SAM) [42] and ankyrin repeats [43].
Since the cDNA clone obtained from the two-hybrid
screen against coilin(C214) appears to be incomplete (it
lacks a translational start sequence), we conducted PCR
on a human brain cDNA library using a forward primer
specific to the translation start of another EB-1/AIDA-1
isoform, AIDA-1a, and a reverse primer specific to the 3'
end of the isolated cDNA. Sequencing of the resultant
product demonstrated that we amplified a novel EB-1/
AIDA-1 isoform, which we have termed AIDA-1c (Figure
1A). AIDA-1c is 426 amino acids length and has a pre-
dicted molecular weight of 48 kDa. We have not tested if
AIDA-1c binds the AID domain of the amyloid-β  protein
precursor. Alignment of the protein sequence of AIDA-1c
with AIDA-1a demonstrates that the C-terminus of AIDA-
1c differs from AIDA-1a (Figure 1B). Furthermore, while
the N-terminus of AIDA-1c is identical to AIDA-1a, AIDA-
1c contains an internal deletion between the SAM and
PTB domains not found in AIDA-1a or other known iso-
forms. We could not amplify a product that contained the
translational start of AIDA-1b and the 3' exon of AIDA-1c.
To get an approximate idea as to the expression profile of
AIDA-1c mRNA, we conducted a multi-tissue Northern
blot using a probe derived from the unique 3' end of
AIDA-1c (Figure 2A). This probe should therefore discrim-
inate between AIDA-1c and other isoforms, unless they
share the same 3' exon and untranslated region as found
for AIDA-1c. A band of approximately 4 kbp in length cor-
responding to the AIDA-1c message is detected only in
neuronal tissue (recall that a brain cDNA library was used
in the isolation of AIDA-1c). To explore if AIDA-1c expres-
sion can be detected in cell lines, we conducted nested
PCR using primers specific to the 3' end of AIDA-1c on
cDNA made from various cancer lines. As shown in Figure
2B, AIDA-1c expression can be detected in all six cell lines.
We also observed expression of AIDA-1c in HeLa cells, as
assessed by RT-PCR (Figure 2B, lower panel). These results
show that AIDA-1c is detected in cancer cells and is
expressed at the highest level in brain among normal tis-
sues. However, since nested- and RT-PCR are much more
sensitive techniques than Northern blotting, we cannot
exclude the possibility that low levels of this isoform are
present in normal tissues.
A 47kDa. protein reactive to AIDA-1 antibodies interacts 
with the C-terminus of coilin
Since the two-hybrid result indicates that coilin interacts
with a member of the EB-1/AIDA-1 protein family, possi-
bly AIDA-1c, we decided to screen HeLa lysate for EB-1/
AIDA-1 proteins that interact with coilin. As a first step, we
monitored the expression of EB-1/AIDA-1 proteins from
HeLa cytoplasmic and nuclear extract using anti-AIDA-1
antibodies (Zymed, South San Francisco, CA) [37,38].
This antibody was made using a peptide whose sequence
is also present in AIDA-1c, and has been confirmed to spe-
cifically recognize a number of proteins in human brain
extract [37]. By immunoblotting of HeLa lystate, anti-
AIDA-1 detects several proteins in both the cytoplasmic
and nuclear fractions (Figure 3A). In particular, three
prominent proteins, approximately 172, 75, and 47 kDa.
in size, are detected by anti-AIDA-1 in nuclear extract. A
doublet migrating around 62 kDa. in size is also detected,
albeit faintly. To test if any of these proteins interact with
coilin, which is also nuclear, we subjected HeLa nuclear
lysate to immunoprecipitation with anti-AIDA-1 antibod-
ies, followed by SDS-PAGE and Western blotting with
anti-coilin antibodies. We could not detect endogenous
coilin association with any AIDA-1 protein (our unpub-
lished results). However, ectopically expressed myc-
tagged coilin can be specifically co-immunoprecipitated
by anti-AIDA-1 antibodies, but not by normal rabbit
serum (Figure 3B). The interaction between coilin and EB-
1/AIDA-1 proteins is specific, but likely to be weak or tran-
sient given that the input lane accounts for 1/20th the
amount of lysate used in the immunoprecipitation reac-
tions (Figure 3B, lane 1).BMC Cell Biology 2005, 6:23 http://www.biomedcentral.com/1471-2121/6/23
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AIDA-1c is a member of the EB-1/AIDA-1 protein family Figure 1
AIDA-1c is a member of the EB-1/AIDA-1 protein family. (A) Schematic amino acid alignment of some known EB-1/
AIDA-1 isoforms. Accession numbers AY281131 (AIDA-1b) and AY281132 (AIDA-1a) were reported by Ghersi et al., 2004a. 
AF145204 (EB-1) was reported by [39] and does not contain a translational start site. AIDA-1c (AY753193) is from this study. 
AIDA-1b is predicted to be approximately 1250 aa and contains ankrin repeats (denoted by 'A'), Eph-related SAM domains ('S') 
and a phosphotyrosine-binding domain ('PTB'). Boxes with shading or hatching represent variation from the AIDA-1b 
sequence. (B) Amino acid alignment of AIDA-1a versus AIDA-1c.
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To corroborate this result and ascertain which EB-1/AIDA-
1 protein associates with coilin, we incubated total HeLa
or SK-MEL-2 lysate with GST alone or GST fused to the C-
terminal 214 aa of coilin. This region of coilin was used in
the two-hybrid screen and interacts with Sm proteins and
SMN. After extensive washes, the beads were subjected to
SDS-PAGE and Western blotting with anti-AIDA-1 anti-
bodies. No proteins reactive to anti-AIDA-1 antibodies
were recovered over GST beads, but a 47 kDa. protein was
retained by the C-terminal 214 aa coilin fragment in both
HeLa and SK-MEL-2 reactions (Figure 3C, lanes 4 and 6
upper panel). Thus the C-terminus of coilin mediates
interaction with the 47 kDa. EB-1/AIDA-1 nuclear pro-
tein. Of all the known EB-1/AIDA-1 isoforms, only AIDA-
1c and a putative protein found in the GenBank database
(accession number AF164792) closely match the size of
the protein that interacts with the C-terminus of coilin. To
confirm that AIDA-1c migrates through SDS-PAGE gels
with an apparent size of 47 kDa., we purified a His-T7-tag
fusion of AIDA-1c and ran this on a gel with HeLa nuclear
extract. Probing with anti-AIDA-1 demonstrates that His-
T7-AIDA-1c has a mobility of around 52 kDa. (Figure 3D),
indicating that an untagged protein would migrate at 47–
48 kDa. (the His-T7 tag and linker add approximately 4
kDa.).
AIDA-1c interaction with coilin in vivo and in vitro
To establish if AIDA-1c interacts with coilin, as suggested
from the immunoprecipitation and two-hybrid experi-
ments described above, we conducted co-immunoprecip-
itation experiments on lysate from HeLa cells transfected
with empty GFP vector or GFP-AIDA-1c using anti-GFP
antibodies followed by Western blotting with anti-coilin
antibodies. We also tested another nuclear EB-1/AIDA-1
isoform, AIDA-1a, for its ability to associate with coilin in
vivo. As shown in Figure 4A, coilin specifically interacts
with GFP-AIDA-1c, but not GFP alone, despite the large
amount of immunoprecipitated GFP (the anti-GFP signal
in lane 4 (lower panel) has been underexposed six-fold
relative to the signals in lane 5 and 6). YFP-AIDA-1a asso-
ciates with coilin above background levels, but below that
found for AIDA-1c (Figure 4A, upper panel, compare the
signal in lane 6 to that in lane 5). Reprobing of the same
blot verified that both FP-AIDA-1c and FP-AIDA-1a were
expressed and immunoprecipitated equally (lower panel,
compare the anti-GFP signal in lane 5 to that in lane 6).
Therefore, we conclude that AIDA-1a does not form a
complex with coilin as efficiently as AIDA-1c.
To determine if the interaction between AIDA-1c and coi-
lin is direct, we conducted GST-pulldown assays using
AIDA-1c expression is highest in neuronal tissue and is present in cancer lines Figure 2
AIDA-1c expression is highest in neuronal tissue and is present in cancer lines. (A) A Multi-Tissue Northern blot 
(Clontech) was probed with an AIDA-1c specific probe. Re-probing of the same blot with a β -actin probe (bottom panel) is 
shown, verifying the presence of RNA in each lane. (B) (Upper panel) Nested PCR using AIDA-1c specific primers was con-
ducted on cDNA obtained from a variety of cancer cell lines: SK-MEL-2 (melanoma), NIH:OVCAR-3 (ovarian), HCT-15 
(colon), A-549 (non small cell lung carcinoma), MDA-MB-231 (breast), MCF-7 (breast). The positive control lane used AIDA-
1c cDNA as the template. (Lower panel) HeLa expresses AIDA-1c. HeLa RNA was subjected to RT-PCR using an AIDA-1c 
specific primer. No product is observed in the reaction lacking reverse transcriptase (-RT).
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purified recombinant proteins. We found that soluble
full-length coilin is recovered by AIDA-1c fused to GST
(Figure 4B, lane 2). In support of our previous observa-
tions suggesting that the interaction between AIDA-1c and
coilin is weak or transient, coilin binding is abolished
when the assay was carried out in the presence of increas-
ing salt concentrations (Figure 4B, lanes 3–5). These
results indicate that the association between coilin and
A 47 kDa. EB-1/AIDA-1 protein interacts with coilin Figure 3
A 47 kDa. EB-1/AIDA-1 protein interacts with coilin. (A) Cytoplasmic and nuclear extracts from HeLa cells were sub-
jected to Western blotting with anti-AIDA-1 antibodies. (B) Myc-coilin interacts in vivo with EB-1/AIDA-1 nuclear proteins. 
HeLa cells were transfected with myc-coilin and nuclear extract was subjected to immunoprecipitation (IP) with anti-AIDA-1 
antibodies followed by SDS-PAGE and Western blotting with anti-myc antibodies. Normal rabbit serum (NRS) was used as a 
negative IP control. The input lane accounts for 1/20 the amount of lysate used in the IP reactions. (C) HeLa and melanoma cell 
lysates were incubated with a GST-tagged coilin fragment (C214) or GST alone, followed by Western blotting with anti-AIDA-
1 antibodies (upper panels). Pulldowns using HeLa lysate are shown in lanes 3 and 4. Melanoma cell lysate was used in the reac-
tions shown in lanes 5 and 6. Only the 47 kDa. EB-1/AIDA-1 protein binds to the coilin fragment. The blot was subsequently 
probed with anti-GST antibody to verify the loading of the GST and GST-C214 beads (lower panel). The input lanes account 
for 1/20 the amount of lysate used in the pulldown reactions. (D) Purified T7-tagged AIDA-1c protein was run as a control to 
mark the position of the 47 kDa. protein from nuclear extract (NE). The blot was probed with anti-AIDA-1 antibody.
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AIDA-1c associates with coilin in vivo and interacts directly with the C-terminus of coilin in vitro Figure 4
AIDA-1c associates with coilin in vivo and interacts directly with the C-terminus of coilin in vitro. (A) Lysates 
obtained from cells transfected with GFP-only, GFP-AIDA-1c or YFP-AIDA-1a [38] were immunoprecipitated with anti-GFP 
antibodies followed by Western analysis with anti-coilin antibodies (upper panel). Co-immunoprecipitated coilin can be 
observed most clearly in the AIDA-1c IP lane (lane 5). The blot was reprobed with anti-GFP antibodies to monitor the expres-
sion and immunoprecipitation of the GFP-tagged proteins (lower panel). The anti-GFP signal in lane 4 (bottom panel) has been 
underexposed six-fold relative to the signal in lanes 5 and 6. The expression level of GFP-AIDA-1c and YFP-AIDA-1a is low, 
resulting in no signal for these proteins in the input lanes (not shown). Input lanes account for 1/30 the amount of lysate used 
in the IP reactions. (B) AIDA-1c direct interaction with coilin is salt-sensitive. Purified coilin was incubated with GST-AIDA-1c 
in binding buffer containing various concentrations of NaCl. After the beads were washed, Western analysis was conducted 
using anti-coilin antibodies (upper panel). The blot was then stained with Ponceau S to verify that approximately equal amounts 
of GST-AIDA-1c were used in each reaction (lower panel). The input lane accounts for 20% of the protein used in the pull-
down reactions. (C) AIDA-1c directly interacts with the C-terminus of coilin. Purified T7-tagged AIDA-1c was incubated with 
GST or GST-tagged coilin fragments containing either the C-terminal 156 or 214 amino acids of coilin. The blot was subse-
quently stained with Ponceau S to verify that approximately equal amounts of GST-fusions were used in the assay (lower 
panel). The input lane accounts for 20% of the protein used in the pulldown reactions. (D) AIDA-1c competes with Sm pro-
teins for coilin binding sites. A competition experiment is shown wherein individual reactions were set-up containing a fixed 
amount of GST-coilin fragment (GST-C214) and T7-SmB' with increasing amounts T7-AIDA-1c as indicated. As can been seen 
in lane 6, as more AIDA-1c binds to GST-C214, less SmB' is recovered. Lane 2 shows the binding of either AIDA-1c (top) or 
SmB' (bottom) to GST-C214 in the absence of competitor. Input lanes account for 20% of the protein used in the 1X 
reactions.
A
α -coilin
α -GFP
GFP
AIDA-1c
GFP
AIDA-1c
AIDA-1a
AIDA-1a
Input IP
coilin
Lane 1 2 3 4 6 5
C
Input
GST
GST-C214
GST-C156
AIDA-1c α -AIDA1
Ponceau S
Lane 1 2 3 4
Input
1X 3X 9X 27X
GST-C214
SmB'
1 Lane 2 3 4 5 6
AIDA-1c
AIDA-1c
D
B
T7-coilin α -coilin
Ponceau S GST-AIDA1c
Input 150 250 400 500 (mM salt)
Lane 1 2 3 4 5BMC Cell Biology 2005, 6:23 http://www.biomedcentral.com/1471-2121/6/23
Page 8 of 13
(page number not for citation purposes)
AIDA-1c is specific and electrostatic bonds are important
for this interaction.
To verify that the coilin fragment used in the two-hybrid
assay directly interacts with AIDA-1c, we conducted GST-
pulldown experiments with bacterially expressed AIDA-1c
incubated with GST alone or GST fused to aa 362–576 of
coilin (C214). We found that AIDA-1c, detected using
anti-AIDA-1 antibodies, interacts directly with the coilin
fragment but not with GST alone (Figure 4C, upper panel,
compare lane 4 to lane 3). The binding site for AIDA-1c
on coilin was further explored using an additional coilin
C-terminal fragment (aa 420–576, C156) that lacks the
coilin RG box (found between aa 392–420). Recovery of
AIDA-1c is observed in the reaction using GST-C156 of
coilin (Figure 4C, upper panel, lane 2).
AIDA-1c competes with Sm proteins for coilin binding
We have previously shown that the C-terminal 214 aa of
coilin, in addition to AIDA-1c binding, also mediates the
interaction with SMN and Sm proteins, such as SmB' [30].
While the interaction between coilin and SMN involves
the coilin RG box, which is subject to modification by
symmetrical dimethylation [33,34], the binding site for
Sm proteins on coilin has not been defined. However,
competition binding experiments show that Sm proteins
and SMN may have overlapping binding sites on coilin
[30]. Since AIDA-1c binds within the same C-terminal
214 residues of coilin as do SMN and Sm proteins, we
investigated whether AIDA-1c may compete with Sm pro-
teins for coilin binding sites. AIDA-1c can effectively com-
pete with SmB' for coilin binding sites (Figure 4D,
compare the level of SmB' recovered in lane 2 to that in
lane 6). We did not observe a direct interaction between
SMN and AIDA-1c (our unpublished observations). Thus,
the findings that AIDA-1c competes with Sm proteins and
binds downstream of the coilin RG box suggest that Sm
proteins and SMN have overlapping but distinct binding
sites on coilin. The interaction studies also demonstrate
that one function of AIDA-1c may be to modify coilin pro-
tein dynamics.
Cellular localization of ectopically expressed AIDA-1c
Given that AIDA-1c interacts with coilin, and that a
47kDa. protein which is possibly AIDA-1c is found in
nuclear extract, we were interested in assessing the cellular
localization of AIDA-1c by transient transfection into
HeLa cells. As shown in Figure 5, GFP-tagged AIDA-1c is
localized diffusely in the nucleus, excluding nucleoli, with
some staining in the cytoplasm. We did not detect signifi-
cant enrichment of AIDA-1c in CBs (our unpublished
observations). A similar localization pattern has been
observed for AIDA-1a [37,38]. Therefore, interactions
between AIDA-1c and coilin may be taking place in the
nucleoplasm. Indeed, while coilin is highly enriched in
the CB, the majority (70%) of the protein is diffusely
localized throughout the nucleoplasm [25]. To determine
the localization of endogenous EB-1/AIDA-1 proteins, we
stained HeLa cells with antibodies to EB-1/AIDA-1 pro-
teins. Despite the fact that anti-AIDA-1 works well by
immunoblotting, this antibody does not detect nuclear
proteins in HeLa cells by immunofluorescence [37,38]
(our unpublished observations). We are currently devel-
oping an antibody to the unique C-terminus of AIDA-1c
in order to specifically detect this isoform.
Knockdown of EB-1/AIDA-1 proteins by siRNA reduces cell 
viability and disrupts Cajal bodies
The studies described above suggest that a subset of EB-1/
AIDA-1 proteins may play a role in Cajal body protein
dynamics. To further explore this possibility, siRNA was
used to target all known EB-1/AIDA-1 proteins. For this
experiment, cells were treated with EB-1/AIDA-1 siRNA
for 72 hours, followed by nuclear lysate preparation and
Western blotting using anti-AIDA-1 antibodies. Three
prominent bands reactive to anti-AIDA-1 are detected in
nuclear lysate from mock treated cells 172, 75, and 47
kDa. in size (Figure 6A, top panel). The amounts of these
proteins is significantly reduced in extract obtained from
cells treated with EB-1/AIDA-1 siRNA. In fact, the 47 kDa.
protein, which we believe is AIDA-1c, is reduced by 3.5
fold as assessed by densitometric analysis. Reprobing of
the same blot with anti-SMN demonstrates that an
approximately equal amount of nuclear protein was
loaded in each lane.
During these experiments, we noticed an increased rate of
cell death in cells treated with EB-1/AIDA-1 siRNA com-
pared to mock treated. We quantified this phenomenon
Ectopically expressed AIDA-1c is predominantly nuclear Figure 5
Ectopically expressed AIDA-1c is predominantly 
nuclear. HeLa cells transfected with GFP-fused to AIDA-1c 
were processed and stained with DAPI. GFP-AIDA-1c is pre-
dominantly localized in the nucleus.BMC Cell Biology 2005, 6:23 http://www.biomedcentral.com/1471-2121/6/23
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EB-1/AIDA-1 siRNA disrupts Cajal body structure and causes cell death Figure 6
EB-1/AIDA-1 siRNA disrupts Cajal body structure and causes cell death. (A) Endogenous EB-1/AIDA-1 protein levels 
are reduced upon treatment with EB-1/AIDA-1 siRNA. HeLa cells were treated with EB-1/AIDA-1 siRNA (100 nM) for 72 
hours, followed by nuclear extraction and Western blotting using anti-AIDA-1 antibodies. The film with the 47 kDa. protein 
was exposed for a shorter period of time. The blot was reprobed with anti-SMN to verify that equivalent levels of extract 
were loaded on the gel. (B) Coilin and snRNP localization is disrupted upon treatment with actinomycin D. Panel A shows the 
normal localization of coilin in CBs (arrows), along with the DAPI stain of the same cell. Panel B shows the normal localization 
of snRNPs to CBs (arrows) and speckles (arrowheads). Panels C and D are representative images of cells treated with actino-
mycin D. Note that coilin is relocalized to the periphery of the nucleolus (panel C, arrows) and speckles are enlarged (panel D, 
arrowheads) in the presence of actinomycin D. (C) HeLa cells exposed to EB-1/AIDA-1 siRNA (100 nM for 72 hours) were 
subjected to immunofluorescence analysis with antibodies to coilin (red) and snRNPs (Y12) (green). The overlay is shown in 
the far right panel. Arrows mark altered Cajal body structure. The bottom panels show a closer view of another cell with dis-
rupted CB organization and co-localization of coilin and snRNPs.
kDa.
175
83
62
48
anti-AIDA-1
anti-SMN
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EB-1/AIDA-1
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A.BMC Cell Biology 2005, 6:23 http://www.biomedcentral.com/1471-2121/6/23
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by conducting experiments with mock-, EB-1/AIDA-1-, or
control siRNA-treatment followed by cell counting using
the trypan blue exclusion method. The control siRNA
used in this study is functional in that it is processed by
the RISC machinery, but is non-targeting (Dharmacon
Research). Thus this siRNA is an excellent control for off-
target effects. In fact, there is no reduction in cell viability
when using the control siRNA. In contrast, only 45% (+/-
4%) of cells are viable upon treatment with EB-1/AIDA-1
siRNA.
Since EB-1/AIDA-1 siRNA causes cell death and a subset of
EB-1/AIDA-1 isoforms interact with the Cajal body pro-
tein coilin, we investigated if nuclear organization, in
particular Cajal body structure, was disrupted upon treat-
ing cells with EB-1/AIDA-1 siRNA. The normal localiza-
tion of coilin in CBs is shown in Figure 6B (panel A,
arrows), as is the typical distribution of snRNPs in speck-
les and CBs (panel B, arrowheads and arrows, respec-
tively). In contrast, CBs and speckles display altered
structures in the presence of the transcription inhibitor
actinomycin D (Figure 6B, panels C and D, [44]). Specifi-
cally, CBs relocalize to nucleolar caps (panel C, arrows)
and speckles enlarge (panel D, arrowheads). Cells
exposed to EB-1/AIDA-1 siRNA have noticeable changes
in nuclear organization compared to mock- or control
siRNA-treated cells. Notably, coilin and CBs are reorgan-
ized in a manner reminiscent to that observed when treat-
ing cells with actinomycin D (Figure 6C). In contrast,
mock or control treated cells are indistinguishable from
normal cells with regard to CB organization (not shown).
One noticeable difference between the phenotype of EB-
1/AIDA-1 siRNA versus actinomycin D treated cells is that
snRNPs, as assessed by Y12 staining, are co-localized with
coilin in EB-1/AIDA-1 siRNA cells (Figure 6C, arrows).
Previous reports [44] and our work (Figure 6B, panel D)
have shown that snRNPs do not co-localize with coilin in
actinomycin D treated cells. It is conceivable, therefore,
that the observed cell death upon treating cells with EB-1/
AIDA-1 siRNA is the result of altered Cajal body organiza-
tion rather than simply an arrest of transcription. Given
that several EB-1/AIDA-1 proteins are likely to be targeted
by the EB-1/AIDA-1 siRNA, we cannot ascertain the spe-
cific function of AIDA-1c in these experiments. However,
if AIDA-1c does participate in snRNP trafficking through
the CB, then we would expect to observe altered snRNP
transport when AIDA-1c levels are reduced. The presence
of snRNPs in coilin-containing nucleolar cap structures
formed by EB-1/AIDA-1 siRNA treatment is therefore
consistent with a role of AIDA-1c in snRNP displacement
from the CB.
Conclusion
The isolation and partial characterization of AIDA-1c
demonstrates that specific EB-1/AIDA-1 protein isoforms
may regulate the dynamics of coilin protein interactions
in the nucleoplasm. Little is known about the role of
nucleoplasmic coilin, even though this fraction accounts
for the majority of the protein [25]. For example, coilin
could interact with snRNPs in the nucleoplasm and bring
them to the CB. Coilin association with AIDA-1c in the
nucleoplasm might therefore affect the protein composi-
tion of the CB indirectly. If correct, then we would expect
that the specific disruption of AIDA-1c expression would
alter some aspect of snRNP biogenesis or CB function.
Current experiments are underway to test this hypothesis.
It is noteworthy that AIDA-1c expression can be detected
in both neuronal and cancer cells given that Cajal bodies
are prominent in these cells [1]. Curiously, certain neuro-
degenerative disorders such as Spinal Muscular Atrophy
(SMA) dramatically affect neuronal cells even though the
mutant protein (SMN) is ubiquitously expressed. Why is
neuronal tissue so susceptible to disease proteins? One
possible explanation is that neuronal cells, which are
known to undergo a high degree of alternative splicing
[45], cannot tolerate deficiencies in splicing. It may be
that a range of neurodegenerative disorders, through a
variety of mechanisms, affect the level of neuronal alter-
native splicing by disrupting Cajal body function. Conse-
quently, in addition to other cellular processes which are
disturbed in some neurodegenerative disorders, inade-
quate levels of snRNPs may exacerbate the deleterious
effects of the disease protein in neuronal tissue. Interest-
ingly, CBs are not normally found in every human cell but
are present in immortalized or transformed cells [36,46].
The induction of CBs in cancer cells may reflect on the
need for increased levels of snRNPs. Given the presence of
CBs in neuronal and cancer cells, it would not be surpris-
ing if various factors were upregulated in these cell types
to meet their RNP demands. Indeed, EB-1 mRNA is nor-
mally expressed in brain and testis but is dramatically
induced in marrow from patients having a specific acute
lymphocytic leukemia [39]. Likewise, we have found that
AIDA-1c expression can be detected both in brain and cer-
tain cancer cell lines. We propose that AIDA-1c expression
in neuronal and cancer cell lines may facilitate snRNP
biogenesis by modulating the interaction between coilin
and snRNPs.
Methods
Yeast two-hybrid screen and plasmid construction
A human brain cDNA library cloned into the prey vector
pACT2 and pretransformed into the yeast strain Y187
(Clontech) was mated with the strain PJ69-2A harboring
the bait vector pAS2-1-coilin(362–576, C214) per the
manufacturer's instructions. After mating, the yeast were
plated onto medium lacking tryptophan, leucine, histi-
dine and adenine (to select for bait, prey and protein
interaction). Colonies were picked after several days ofBMC Cell Biology 2005, 6:23 http://www.biomedcentral.com/1471-2121/6/23
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incubation and the prey plasmid was isolated and trans-
formed into PJ69-2A containing pAS2-1-C214 or control
bait plasmids to confirm the specificity of the interaction.
Restriction digests and sequencing revealed that nine dif-
ferent prey cDNAs were recovered, one of which appeared
to encode a truncated EB-1/AIDA-1 protein and was
termed CAP36C. The sequence for CAP36C has been sub-
mitted to GenBank and given the accession number
AY356353. For bacterial expression, cDNAs were cloned
into pET28a (Novagen), generating a His-T7-tag fusion, or
pGEX-2T/ pGEX-3X (Amersham Pharmacia), generating a
fusion to GST. Additional constructs were generated
employing standard molecular biological techniques or
have been described previously [47,30,33].
Isolation of AIDA-1c
AIDA-1c was isolated by conducting PCR on a human
brain cDNA library (Clontech) using a forward primer
specific to the translation start of another EB-1/AIDA-1
isoform, AIDA-1a (accession number AY281132), and a
reverse primer specific to the 3' exon of AIDA-1c. The
sequence for AIDA-1c has been submitted to GenBank
and given the accession number AY753193. AIDA-1c was
cloned into various expression vectors by standard molec-
ular biological techniques. We could not amplify a prod-
uct that contained the translational start of AIDA-1b and
the 3' exon of AIDA-1c.
Northern analysis
A Multi-Tissue Northern blot (Clontech) was hybridized
with a 32P-radiolabled cDNA probe for AIDA-1c according
to the manufacturer's instructions. The probe was gener-
ated by PCR using CAP36C DNA as template and primers
designed to amplify a fragment of AIDA-1c downstream
of the PTB domain, including the 3' untranslated region.
Nested- and RT-PCR
The Nested PCR assay was carried out in the DNA Engine
PTC-200 Peltier Thermal Cycler (MJ Research, Watertown,
MA) to assess the expression of AIDA-1c in cultured can-
cer cell lines. The cDNA from six cancer cell lines were
kindly provided by Dr. Laree Hiser (The University of Mis-
sissippi Medical Center): SK-MEL-2 (melanoma), NIH:
OVCAR-3 (ovarian cancer), HCT-15 (colon cancer), A-
549 (non-small cell lung cancer), MDA-MB-231 (breast
cancer) and MCF-7 (breast cancer). Two pairs of nested
primers flanking the AIDA-1c specific sequence on the 3'
end of the AIDA-1c cDNA were used to amplify the
sequence. Plasmid containing the AIDA-1c cDNA and
water served as positive and negative controls for the reac-
tion, respectively. Each reaction had 30 cycles and, after
the first reaction, the product was diluted 50 fold to serve
as the template for the second pair of primers. For RT-PCR
reactions, DNA-free RNA was isolated from HeLa cells
using the RNAqueous-4PCR DNA-free RNA isolation kit
(Ambion, Austin, TX). The RNA was reverse-transcribed
with the Thermoscript RT-PCR kit (Invitrogen) using an
antisense primer for 45 minutes at 50°C. The antinsense
primer binds the 3' UTR of AIDA-1c. A forward primer
which binds to the 3' coding sequence of AIDA1c was
used in combination with the antisense primer to amplify
the corresponding cDNA frangment (25 cycle reaction).
Antibodies
A polyclonal anti-AIDA-1 antibody was purchased from
Zymed (South San Francisco, CA) A monoclonal antibody
to coilin [48] was a gift from Greg Matera (Case Western
Reserve University). We also utilized a commercially
available coilin mnonclonal antibody (ab11822) from
Abcam (Cambridge, MA). Anti-T7 (1:1000) was obtained
from Novagen (Madison, WI). Antibodies to GFP were
from BD Biosciences, Palo Alto, CA (polyclonal, catalog
number 632459) or Roche, Indianapolis, IN (mono-
clonal, catalog number 1814460). Myc and GST antibod-
ies were obtained from Santa Cruz Biotechnology, Santa
Cruz, CA
Cell Culture, Transfection, Immunofluorescence, and 
Immunoprecipitation
HeLA cells were cultured, transfected with Superfect (Qia-
gen, Valencia, CA) and processed as described [47,30,33].
For immunofluorescence, cells were grown on chamber-
slides and fixed with 4% paraformaldeyde followed by
permeabilizaton with 0.5% Triton X-100. The permeable
cells were then blocked with 10% normal goat serum for
30 min and probed with the corresponding primary and
secondary antibodies for 30 min each. For co-immuno-
precipitation experiments, the protocol detailed in [47]
was followed with a few modifications. Briefly, cells were
lysed in a modified RIPA buffer (50 mM Tris, pH 7.5, 150
mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1%
SDS, 2 mM EDTA plus 1 tablet of complete protease
inhibitor cocktail (Roche, Mannheim, Germany) per 50
ml lysis solution). The lysates were then repeatedly passed
through a 25 gauge needle to shear DNA or passed
through a Qiashredder column (Qiagen) and subject t
incubation with the appropriate antibodies for 1 hour at
4°C with gentle shaking. Following the addition of pro-
tein A or G Sepharose (Amersham Pharmacia, Uppsala,
Sweden) for 1 hour with gentle shaking, the beads were
washed with 1 ml lysis solution 5 times. The beads were
resuspended in 5X SDS loading buffer, boiled, and subject
to SDS-PAGE and Western blotting as described [47].
Input lanes typically account for 1/20 to 1/50 the amount
of lysate used in the immunoprecipitation reactions. For
co-immunoprecipitation experiments on nuclear protein,
nuclear extract was made using the NE-PER kit from
Pierce, followed by dilution of the extract to 1 ml with
mRIPA and immunoprecipitaton as described above.BMC Cell Biology 2005, 6:23 http://www.biomedcentral.com/1471-2121/6/23
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Where indicated, actinomycin D was used at 2.5 µg/ml for
two hours.
In vitro binding assays
GST- and His-tagged constructs, after transformation into
E. coil BL21(DE3)pLysS cells, were indiced and purified as
described [30]. In a binding reaction, approximately 1 ug
of His-T7-tagged protein was incubated with 1 ug of the
GST-fusion protein in 1 ml of mRIPA plus 2 mM DTT.
After incubation for 1 hour at 4°C with gentle inversion,
the beads were washed 5 times (1 ml each) with mRIPA
plus DTT, resuspended in 15 ul 5X SDS loading buffer,
boiled and subjected to SDS-PAGE. Anti-T7 (1:1000;
Novagen, Madison, WI) was used to detect SmB' and anti-
AIDA-1 was used to detect AIDA-1c. Competition experi-
ments were performed as described in [30], except that
increasing amounts of AIDA-1c were used. Input lanes
account for 1/5 the amount of lysate used in the pulldown
reactions. Additional NaCl was added to the binding
buffer where indicated.
SiRNA knockdowns and viability assays
SiRNAs to the clone obtained in the two-hybrid screen
described above (accession number AY356353) were
obtained from Dharmacon Research, as was control
siRNA (no. D-001210-01-05). The siRNA should target all
known EB-1/AIDA-1 isoforms. SiRNA was introduced
into HeLa cells using Lipofectamine 2000 per the manu-
facturers' directions (Invitrogen). To assess the knock-
down of endogenous EB-1/AIDA-1 proteins, EB-1/AIDA-1
siRNA was added to cells at a final concentration of 100
nM, followed by 72 hours of incubation. Nuclear extract
was then made using the NE-PER kit from Pierce, fol-
lowed by Western blotting with anti-AIDA-1 and anti-
SMN antibodies. Densitometric analysis of the films was
conducted using ImageQuant software. To monitor the
viability of cells treated with EB-1/AIDA-1 siRNA, equal
numbers of cells were seeded into three wells of a six-well
plate. One well was mock treated (no siRNA), while the
other two received 100 nM of control or EB-1/AIDA-1
siRNA. After 72 hours of incubation, the cells were
counted and scored for viability using Trypan blue. The
experiment was done in triplicate.
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